Preclinical Studies
Besides fundamental scientific research, we also organized and carried out a set of applied studies of the biomedical properties of relict bacteria and their impact on higher organisms
Preclinical studies of the biomedical properties of the Bacillus F strain were carried out over several years at leading pharmaceutical and medical centers using methods that are adopted for assessing the effectiveness of new pharmaceutical substances
The results we have obtained indicate the prospects of developing a new generation of natural, safe and effective drugs based on relict microorganisms from permafrost that work at the molecular and cellular levels.
Biologically active substances extracted from relict bacteria have a systemic positive effect on the human body, have no side effects and are superior in effectiveness to reference pharmaceuticals.
Studies have also been conducted on volunteers and they have confirmed the significant positive effect of relict biologically active substances on the human body under various pathologies.
Biologically active substances extracted from relict bacteria have a systemic positive effect on the human body, have no side effects and are superior in effectiveness to reference pharmaceuticals.
Studies have also been conducted on volunteers and they have confirmed the significant positive effect of relict biologically active substances on the human body under various pathologies.